Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 17;14(12):1668.
doi: 10.3390/life14121668.

International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives

Francesco Pesce  1   2 , Maria Vadalà  2 , Edgar Almeida  3 , Beatriz Fernandez  4 , Denis Fouque  5 , Jolanta Malyszko  6 , Kai Schmidt-Ott  7 , Peter Stenvinkel  8 , David C Wheeler  9 , Samuel Seidu  10 , Ana Cebrian  11 , Nikolay Dimov  12 , Marta Blanco Pardo  13 , Ieva Ziedina  14 , Nayaf Habashi  15 , Joaquin Manrique  16 , Sofia Homem De Melo Marques  17 , Marco Antonio Vaca Gallardo  18 , Larisa Shehaj  19 , Milena Krasimirova Nikolova Vlahova  20 , Luis Mendonça  21 , Sara Ksiazek  22 , Pierangelo Veltri  23 , Giuseppe Pezzi  24 , Gemma Patella  25 , Greta Borelli  26 , Michele Provenzano  27 , Loreto Gesualdo  28
Affiliations
Review

International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives

Francesco Pesce et al. Life (Basel). .

Abstract

Chronic kidney disease (CKD) is a progressive condition that affects more than 10% of the population worldwide, accounting for more than 843 million (M) individuals. The prevalence of CKD (844 M patients) is higher than that of diabetes mellitus (422 M patients), cancer (42 M patients), and HIV (37 M patients), but people are often less aware of it. Global expert groups predict reductions in the nephrology workforce in the next decade, with a declining interest in nephrology careers. Over time, KDIGO guidelines have also focused on topics related to the prevention or management of CKD patients in real-life settings. On these premises, a new educational program with international experts in the field of nephrology took place from November 2022 until March 2023 in Milan, Italy. This multinational masterclass provided an educational platform providing unbiased education on diagnosis and treatment by sharing the most recent research data on CKD and comorbidities, therefore creating a snowball effect to increase the implementation of best practices worldwide, using examples from 'real-life' patient outcomes. This paper provides an overview of the International Nephrology Masterclass (INM) concept, summarizing the key lectures and discussions, and giving an outline of future key developments.

Keywords: CKD; diabetes; disease; educational; gender; genetics; hypertension; kidney; masterclass; nephrology.

PubMed Disclaimer

Conflict of interest statement

M.P. is consultant and received honoraria from AstraZeneca and Bayer, received honoraria from Menarini. F. P received speaker honoraria from AstraZeneca, Bayer, GSK, Otsuka.L.G. received research fundings from Abionyx, Sanofi, Werfen, Astellas, AstraZeneca, Travere, Sandoz, Baxter, Mundipharma, Pharmadoc, Retrophin, GSK, Novartis, Chinook. D.C.W declared disclosures: honoraria and/or consultancy fees from Amgen, AstraZeneca, Astellas, Boehringer Ingelheim, Bayer, Gladerma, GlaxoSmithKline, Gilead, Janssen, Napp, Merck Sharp and Dohme, Pharmacosmos, ProKidney, Vifor and Zydus. The other authors declared no conflicts of interest.

Figures

Figure 1
Figure 1
Models to increase awareness of chronic kidney disease.
Figure 2
Figure 2
Key messages of the discussed topic.
See this image and copyright information in PMC

References

    1. Foreman K.J., Marquez N., Dolgert A., Fukutaki K., Fullman N., McGaughey M., Pletcher M.A., Smith A.E., Tang K., Yuan C.W., et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392:2052–2090. doi: 10.1016/S0140-6736(18)31694-5. - DOI - PMC - PubMed
    1. Jager K.J., Kovesdy C., Langham R., Rosenberg M., Jha V., Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial. Transplant. 2019;34:1803–1805. doi: 10.1093/ndt/gfz174. - DOI - PubMed
    1. Younes S., Mourad N., Safwan J., Dabbous M., Rahal M., Al Nabulsi M., Sakr F. Chronic kidney disease awareness among the general population: Tool validation and knowledge assessment in a developing country. BMC Nephrol. 2022;23:266. doi: 10.1186/s12882-022-02889-2. - DOI - PMC - PubMed
    1. Schieppati A., Remuzzi G. Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications. Kidney Int. Suppl. 2005;68:S7–S10. doi: 10.1111/j.1523-1755.2005.09801.x. - DOI - PubMed
    1. Liao X., Shi K., Zhang Y., Huang X., Wang N., Zhang L., Zhao X. Contribution of CKD to mortality in middle-aged and elderly people with diabetes: The China Health and Retirement Longitudinal Study: CKD was a chronic stressor for diabetics. Diabetol. Metab. Syndr. 2023;15:122. doi: 10.1186/s13098-023-01083-0. - DOI - PMC - PubMed

LinkOut - more resources